Meryl Nass, MD
Diplomate, American Board of Internal Medicine
Mount Desert Island Hospital                                                               
Bar Harbor, ME 04609                                                                 
(207) 288-5081 ext. 220 or pager 447
cell: (207) 522-5229                                 
Professional Chronology

Researcher, Author, Public Speaker, Expert Witness

Epidemiology and Biological Warfare:


Medical Ethics

Consultant or Reviewer:

Medical Advisory Board Member:

Testimonies (invited)

Academic Publications

  1. Nass M. Letter. Safety of the smallpox vaccine among military recipients.
    JAMA. 2003 ;290:2123-4.
  2. Nass M. Anthrax Vaccine: Caveat Emptor (Let the Buyer Beware). Current Treatment Options in Infectious Disease 2003;5:361-4.
  3. Nass M and Nicholson G. Anthrax Vaccine: Historical Review and Current Controversies. Journal of Nutritional and Environmental Medicine 2002; 12: 277-86.
  4. Nicholson GL, Berns P, Nasrall MY, Haier J, Nicholson NL and Nass M. Gulf War Illnesses: Chemical, Biological and Radiological Exposures Resulting in Chronic Fatiguing Illnesses Can be Identified and Treated. J Chronic Fatigue Syndrome 2003; 11:135-154.
  5. Nass M. Author Reply. American Journal of Public Health 2002; 92: 1708-9.
  6. Nass M. Anthrax Vaccine Not Safe and Effective (letter). Emergency Medicine News, July 2002; 24: 44.
  7. Nass M. The Anthrax Vaccine Program, and an Analysis of the CDC’s Recommendations for Vaccine Use. American Journal of Public Health, 2002; 92: 715-21.
  8. Nass M. Who is Protecting the Public Health? Z Magazine, April 2002; 14: 7-10. 
  9. Nass M. Anthrax Threat is Real (letter). Technology Review, October 2001; 104: 2 MIT.
  10. Nicholson GL, Nass M, Nicholson NL. The Anthrax Vaccine Controversy—Questions about its Efficacy, Safety and Strategy. Medical Sentinel, 2000; 5: 97-101.
  11. Nicholson GL, Nass M, Nicholson NL. Anthrax Vaccine: Controversy Over Safety and Efficacy. Antimicrobics and Infectious Disease Newsletter, 2000; 18:1-6.
  12. Nass M. Should the Military Suspend Its Anthrax Vaccine Program? Physicians Weekly, June 19, 2000; 17:1.
  13. Nass M. The Anthrax Dilemma: Safety Issues Revisited. Medicine and Global Survival, 1999; 6: 54.
  14. Multiple Chemical Sensitivity: A 1999 Consensus. Archives of Environmental Health, 1999; 54, 147–149.
  15. Nass M. Biological Warfare and Vaccines: Anthrax. Applied Science and Analysis Newsletter, April 15, 1999: 10-11, continued in later issues.
  16. Nass M. Anthrax vaccine: Model of a response to the biological warfare threat. Infectious Disease Clinics of North America, 1999; 13: 187-208.
  17. Sidel V, Nass M, Ensign T. The Anthrax Dilemma. Medicine and Global Survival, 1998; 5: 97-104.
  18. Nass M. Will anthrax vaccine help prevent biological warfare? Defense Systems International, Fall 1998. 35-39. (reprint of number 20).
  19. Nass M. Biological Warfare (letter). The Lancet, 1998; 352: 491-2.
  20. Nass M. Anthrax Vaccine and the Prevention of Biological Warfare? Applied Science and Analysis Newsletter, April 30, 1998: 1, 23-25, 32.
  21. Report of the Subgroup on Investigation of Alleged Use or Release of Biological or Toxin Weapons Agents. Federation of American Scientists Working Group on Biological Weapons Verification, April 1996.
  22. Nass M. The Choice is Between Arms Control and Abolition. Medicine and Global Survival, 1995; 2: 180-181.
  23. Nass M. Germ Warfare: Time Now for Verifiable Disarmament (Op-Ed). Interpress News Service (syndicated), March 1993.
  24. Nass M. Anthrax Epizootic in Zimbabwe 1978-1980: Due to Deliberate Spread? PSR Quarterly, 1992; 2: 198-209.
  25. Nass M. Zimbabwe’s Anthrax Epidemic. Covert Action, 1992; 43: 12-18, 61.
  26. Nass M. Can Biological, Toxin, and Chemical Warfare Be Eliminated? Politics and the Life Sciences, 1992; 11: 30-32.
  27. Nass M. Author reply. PSR Quarterly, 1991; 1: 230.
  28. Nass M. The Labyrinth of Biological Defense. PSR Quarterly, 1991; 1: 24-30.
  29. Nass M, Langford HG, Jackson JF, Parent AD. Acromegaly. Journal of the Mississippi State Medical Association, 1985; 26: 251-255.
  30. Zeitlin M, Masangkay M, Consolacion M, Nass M. Breastfeeding and Nutritional Status in Depressed Areas of Greater Manila, Phillippines. Ecology of Food and Nutrition, 1978; 7: 103-113.
  31. Grant CK, Adams EP, Nass M. Appearance of Cytolytic Antibodies in Sheep Lymph Following Immunisation with Tumour Cells: Identification of Antibody Subclasses. Australian Journal of Experimental Biology and Medical Science, 1976; 53: 381-387

  Dr. Nass’ papers have been included in the curricula at Stanford Medical School, Harvard’s Kennedy School of Government and other graduate and undergraduate programs.

Articles written about Dr. Nass

Books that have discussed Dr. Nass’ research and writing